Skip to content

Clinical trials

Phase 4 Diabetes Mellitus, Type 2 trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Diabetes Mellitus, Type 2 Phase: Phase 4 Country / region: Canada Clear all

66 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20024
20033
20053
20064
20072
20084
20094
20105
20113
20123
20134
20144
20157
20162
20172
20183
20191
20201
20211
20221
20231
20252
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed57
Recruiting2
Terminated2
Unknown status2
Withdrawn1
Not yet recruiting1
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Eli Lilly and Company7
GlaxoSmithKline7
Novo Nordisk A/S6
Sanofi5
Boehringer Ingelheim4
AstraZeneca3
Unity Health Toronto3
University Health Network, Toronto3
Canadian Medical and Surgical Knowledge Translation Research Group2
Centre hospitalier de l'Université de Montréal (CHUM)2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Diabetes Mellitus, Type 266
Diabetes Mellitus25
Insulin Resistance7
Cardiovascular Diseases4
Coronary Artery Disease4
Heart Failure3
Hypertension3
Obesity3
Angina Pectoris2
Diabetes Mellitus, Type 12

Trials

Showing 1 to 25 of 66. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.